138 related articles for article (PubMed ID: 32038795)
21. Induction of cytochrome P450-dependent monooxygenase in mouse liver and kidney by rutaecarpine, an alkaloid of the herbal drug Evodia rutaecarpa.
Ueng YF; Wang JJ; Lin LC; Park SS; Chen CF
Life Sci; 2001 Nov; 70(2):207-17. PubMed ID: 11787945
[TBL] [Abstract][Full Text] [Related]
22. Chlorzoxazone metabolism is increased in fasted Sprague-Dawley rats.
Wan J; Ernstgård L; Song BJ; Shoaf SE
J Pharm Pharmacol; 2006 Jan; 58(1):51-61. PubMed ID: 16393464
[TBL] [Abstract][Full Text] [Related]
23. Obesity-induced increase of CYP2E1 activity and its effect on disposition kinetics of chlorzoxazone in Zucker rats.
Khemawoot P; Yokogawa K; Shimada T; Miyamoto K
Biochem Pharmacol; 2007 Jan; 73(1):155-62. PubMed ID: 17049493
[TBL] [Abstract][Full Text] [Related]
24. Effects of acute renal failure on the pharmacokinetics of chlorzoxazone in rats.
Moon YJ; Lee AK; Chung HC; Kim EJ; Kim SH; Lee DC; Lee I; Kim SG; Lee MG
Drug Metab Dispos; 2003 Jun; 31(6):776-84. PubMed ID: 12756212
[TBL] [Abstract][Full Text] [Related]
25. Identification of the microsomal oxidation metabolites of rutaecarpine, a main active alkaloid of the medicinal herb Evodia rutaecarpa.
Ueng YF; Yu HJ; Lee CH; Peng C; Jan WC; Ho LK; Chen CF; Don MJ
J Chromatogr A; 2005 May; 1076(1-2):103-9. PubMed ID: 15974075
[TBL] [Abstract][Full Text] [Related]
26. [Changes of CYP2E1 activity in diabetic rat model].
Li L; Zhang Y
Yao Xue Xue Bao; 1998 Dec; 33(12):891-5. PubMed ID: 12016852
[TBL] [Abstract][Full Text] [Related]
27. The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes.
Ueng YF; Jan WC; Lin LC; Chen TL; Guengerich FP; Chen CF
Drug Metab Dispos; 2002 Mar; 30(3):349-53. PubMed ID: 11854157
[TBL] [Abstract][Full Text] [Related]
28. Chlorzoxazone metabolism by winter flounder liver microsomes: evidence for existence of a CYP2E1-like isoform in teleosts.
Wall KL; Crivello J
Toxicol Appl Pharmacol; 1998 Jul; 151(1):98-104. PubMed ID: 9705891
[TBL] [Abstract][Full Text] [Related]
29. Chronic administration of caderofloxacin, a new fluoroquinolone, increases hepatic CYP2E1 expression and activity in rats.
Liu L; Miao MX; Zhong ZY; Xu P; Chen Y; Liu XD
Acta Pharmacol Sin; 2016 Apr; 37(4):561-70. PubMed ID: 26838075
[TBL] [Abstract][Full Text] [Related]
30. Development of a non-high pressure liquid chromatography assay to determine [14C]chlorzoxazone 6-hydroxylase (CYP2E1) activity in human liver microsomes.
Draper AJ; Madan A; Latham J; Parkinson A
Drug Metab Dispos; 1998 Apr; 26(4):305-12. PubMed ID: 9531516
[TBL] [Abstract][Full Text] [Related]
31. Mechanism-based inactivation of human liver microsomal CYP3A4 by rutaecarpine and limonin from Evodia fruit extract.
Iwata H; Tezuka Y; Kadota S; Hiratsuka A; Watabe T
Drug Metab Pharmacokinet; 2005 Feb; 20(1):34-45. PubMed ID: 15770073
[TBL] [Abstract][Full Text] [Related]
32. The effects of alcohol and diallyl sulphide on CYP2E1 activity in humans: a phenotyping study using chlorzoxazone.
Loizou GD; Cocker J
Hum Exp Toxicol; 2001 Jul; 20(7):321-7. PubMed ID: 11530830
[TBL] [Abstract][Full Text] [Related]
33. Selective effects of nitric oxide on the disposition of chlorzoxazone and dextromethorphan in isolated perfused rat livers.
Vuppugalla R; Mehvar R
Drug Metab Dispos; 2006 Jul; 34(7):1160-6. PubMed ID: 16621933
[TBL] [Abstract][Full Text] [Related]
34. Effect of the acute-phase response on the pharmacokinetics of chlorzoxazone and cytochrome P-450 2E1 in vitro activity in rats.
Rockich K; Blouin R
Drug Metab Dispos; 1999 Sep; 27(9):1074-7. PubMed ID: 10460809
[TBL] [Abstract][Full Text] [Related]
35. Rutaecarpine effects on expression of hepatic phase-1, phase-2 metabolism and transporter genes as a basis of herb-drug interactions.
Zhu QN; Zhang D; Jin T; Wu Q; Liu J; Lu YF
J Ethnopharmacol; 2013 May; 147(1):215-9. PubMed ID: 23510861
[TBL] [Abstract][Full Text] [Related]
36. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans.
Wang Z; Hall SD; Maya JF; Li L; Asghar A; Gorski JC
Br J Clin Pharmacol; 2003 Jan; 55(1):77-85. PubMed ID: 12534643
[TBL] [Abstract][Full Text] [Related]
37. Effects of Evodia rutaecarpa and rutaecarpine on the pharmacokinetics of caffeine in rats.
Tsai TH; Chang CH; Lin LC
Planta Med; 2005 Jul; 71(7):640-5. PubMed ID: 16041650
[TBL] [Abstract][Full Text] [Related]
38. Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity.
Raucy JL; Schultz ED; Wester MR; Arora S; Johnston DE; Omdahl JL; Carpenter SP
Drug Metab Dispos; 1997 Dec; 25(12):1429-35. PubMed ID: 9394034
[TBL] [Abstract][Full Text] [Related]
39. Mechanism-based inhibition of CYPs and RMs-induced hepatoxicity by rutaecarpine.
Zhang FL; He X; Zhai YR; He LN; Zhang SC; Wang LL; Yang AH; An LJ
Xenobiotica; 2015; 45(11):978-89. PubMed ID: 26053557
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the impact of 16-dehydropregnenolone on the activity and expression of rat hepatic cytochrome P450 enzymes.
Ramakrishna R; Bhateria M; Singh R; Bhatta RS
J Steroid Biochem Mol Biol; 2016 Oct; 163():183-92. PubMed ID: 27224941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
